Greater cancer detection is possible with 4-D PET image reconstruction
Study focuses on the benefit of 4D PET imaging using state-of-the-art image reconstruction with motion correction for tumor detection
2011-06-07
(Press-News.org) San Antonio, Texas (June 6, 2011)—A study introduced at SNM's 58th Annual Meeting is advancing a positron emission tomography (PET) imaging method that uses new 4D image reconstruction to achieve the highest diagnostic capability for the detection of cancer. Mounting evidence shows that PET imaging, which provides visual representations of bodily functions, is significantly more sensitive when used with cutting-edge 4D image reconstruction technology that accounts for patient respiration and produces clearer, more easily interpreted images.
"PET imaging with 4D image reconstruction could potentially help with early cancer detection, which is an imperative in the field of nuclear oncology," says Si Chen, lead author of the study, Johns Hopkins School of Medicine, Baltimore, Md. "The results of this study and our other studies indicate that the sensitivity of small cancer lesion detection for patients will likely benefit from this novel image reconstruction method, which incorporates an accurate and patient-specific respiratory motion estimation algorithm we previously developed. The improved diagnostic accuracy would allow physicians a more informed understanding of a patient's situation in order to provide better treatment planning for the best possible outcome."
The objective of the study was to quantify the improvement of PET image quality using the 4D PET image reconstruction method with respiratory motion compensation compared to a more conventional 3D PET image reconstruction method. The researchers evaluated the image reconstruction methods using the receiver operating characteristic (ROC) methodology, which is based on signal detection theory widely adopted in diagnostic radiology. A ROC curve is a graphical plot of the sensitivity versus specificity for lesion detection based on the reconstructed PET images. Realistically simulated PET images were employed in this evaluation study using the 4D XCAT phantom—a digital anthropomorphic phantom that realistically models a typical patient's anatomy, respiratory and cardiac motions. A total of twelve spherical tumors of 10mm diameter were planted inside the lungs and liver of the phantom, which was input to realistic simulation of PET data acquisition using another methodology called Monte-Carlo simulation. The simulated PET data were then reconstructed using both imaging reconstruction methods. The researchers used a mathematical observer, i.e., channelized hotelling observer (CHO), to mimic the interpretation of these PET images by human observers.
Using these methodologies, researchers were able to compare the sensitivity and specificity of the two image reconstruction methods and found that the 4D PET image reconstruction method with respiratory compensation improved the detection sensitivity for the cancer lesions in the liver and lungs. This indicates that evaluation of cancer for lesions smaller than 10 millimeters could be enhanced by compensating for respiratory motion with the 4D image reconstruction method.
INFORMATION:
Scientific Paper 150: S. Chen, B.M.W. Tsui, Johns Hopkins School of Medicine, Baltimore, MD; "Evaluation of a new 4D PET image reconstruction method with respiratory motion compensation in a CHO study," SNM's 58th Annual Meeting, June 4-8, 2011, San Antonio, TX.
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-06-07
San Antonio, Texas (June 6, 2011)—Preliminary research presented at SNM's 58th Annual Meeting is breaking new ground for the development of a brand new hybrid molecular imaging system. Simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) is providing important diagnostic information about soft tissues and physiological functions throughout the body. Scans focused on screening suspicious lesions for cancer are already comparable to more conventional molecular imaging methods. Further research could lead to the clinical use of PET/MRI as an ...
2011-06-07
San Antonio, Texas (June 6, 2011)—A study presented at SNM's 58th Annual Meeting focuses on the effect that breathing irregularities have on the accuracy of 4D positron emission tomography (PET) scans and outlines a PET imaging method that reduces "motion artifacts" or image blurring arising from respiratory motion. Non-gated PET imaging with 4D computed tomography may be useful for imaging patients who do not benefit from the use of respiratory gating, most notably patients with erratic breathing.
"Breathing irregularities can lead to significantly underestimated lesion ...
2011-06-07
San Antonio, Texas (June 6, 2011)—Scientists presented new research at SNM's 58th Annual Meeting that has the potential to help physicians detect breast cancer by imaging the proliferation of blood vessels carrying oxygen and nutrients to breast tumors. Their study is evaluating a new imaging agent that is naturally drawn to angiogenesis—the development of new blood vessels in tissues both normal and cancerous. This process turns malignant during the growth stage of many cancerous tumors including those in breast tissue.
"The positive outcomes of this study are encouraging ...
2011-06-07
San Antonio, Texas (June 6, 2011)—A study introduced at SNM's 58th Annual Meeting may lead to the next wave of cancer imaging by helping to develop a molecular imaging agent that detects many malignant cancers' incessant development of blood vessels—a process called angiogenesis. A protein biomarker known as CD105 has been shown to indicate tumor angiogenesis in cancer patients.
"Non-invasive molecular imaging is a critical component of 21st century personalized medicine, and one of the hallmarks of cancer is angiogenesis," says Weibo Cai, PhD, assistant professor of ...
2011-06-07
San Antonio, Texas (June 6, 2011)—Definitive proof of an adverse effect of chronic marijuana use revealed at SNM's 58th Annual Meeting could lead to potential drug treatments and aid other research involved in cannabinoid receptors, a neurotransmission system receiving a lot of attention. Scientists used molecular imaging to visualize changes in the brains of heavy marijuana smokers versus non-smokers and found that abuse of the drug led to a decreased number of cannabinoid CB1 receptors, which are involved in not just pleasure, appetite and pain tolerance but a host of ...
2011-06-07
San Antonio, Texas (June 6, 2011)—Researchers the world over are advancing positron emission tomography (PET) as an effective method of early detection for Alzheimer's disease, a currently incurable and deadly neurological disorder. Three studies presented at SNM's 58th Annual Meeting are providing new insights into the development of Alzheimer's disease while opening the door to future clinical screening and treatments.
According to the World Health Organization, an estimated 18 million people worldwide are currently living with Alzheimer's disease—a number projected ...
2011-06-07
San Antonio, Texas (June 6, 2011)—A new study presented at SNM's 58th Annual Meeting could throw open the door to a recently established area of obesity research. Investigators have developed a novel molecular imaging agent that targets estrogenic mechanisms in the brain to find out what effect an enzyme called aromatase has on body mass index (BMI), a measurement of body fat based on height and weight. Aromatase is crucial for the production of estrogen in tissues throughout the body, including the brain.
According to the World Health Organization, worldwide obesity ...
2011-06-07
San Antonio, Texas (June 6, 2011)—Researchers are halting kidney cancer with a novel form of radioimmunotherapy that zeroes in on antigens associated with renal cell carcinoma. Patients with progressive kidney cancer receiving up to three doses of the therapy show dramatic slowing of cancer growth and stabilization of their disease.
"This study is another step forward in developing a cancer therapy that has the potential to provide additional treatment options for patients with renal cell carcinoma," says Wim Oyen, MD, professor and chairman of the department of nuclear ...
2011-06-07
San Antonio, Texas (June 6, 2011)—Research introduced at SNM's 58th Annual Meeting could be a sign of hope for patients with neuroendocrine cancer not responding well to standard therapies. Most radiotherapies use medical isotopes that emit beta radiation. The therapy in this study employs alpha particles, which have potential for higher potency. In fact, one single atom could be enough to kill an entire cancer cell.
"Until now, the usage of alpha radionuclides was limited to direct injection into the tumor or the use of only very small doses," says Clemens Kratochwil, ...
2011-06-07
San Antonio, Texas (June 6, 2011)—Investigators at SNM's 58th Annual Meeting are presenting results from a phase 1 clinical trial for a cancer therapy that has the potential to kill colorectal tumors with less destruction of healthy tissue. Further research could lead to the use of this radioimmunotherapy to eliminate residual cancer after surgery or as a standard treatment to keep tumors from returning or spreading to other organs.
"Compared to the conventional way of guiding radiation to tumors with radiolabeled antibody, pretargeted radioimmunotherapy offers an attractive ...
LAST 30 PRESS RELEASES:
[Press-News.org] Greater cancer detection is possible with 4-D PET image reconstruction
Study focuses on the benefit of 4D PET imaging using state-of-the-art image reconstruction with motion correction for tumor detection
